Cardiovascular Drugs and Therapy Template
Get your Cardiovascular Drugs and Therapy paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.2
How to Use the Cardiovascular Drugs and Therapy Template | A Step-by-Step Guide
Authored by Sumalatha Gangadhar | Published on 3 August, 2026
Submitting to Cardiovascular Drugs and Therapy goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Cardiovascular Drugs and Therapy guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
What is the Cardiovascular Drugs and Therapy Template?
It is a manuscript shell aligned to Cardiovascular Drugs and Therapy. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Cardiovascular Drugs and Therapy journal page before you draft.
What's actually in a Cardiovasc Drugs Ther submission:
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Cardiovascular Drugs and Therapy guide for authors lists, and cite figures and tables in order.
What separates a clean submission from one that gets kicked back:
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Cardiovascular Drugs and Therapy guide for authors before you submit.
What does this Cardiovascular Drugs and Therapy Template include?
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
Steps to Use This Template with SciSpace Agent
- Click Start Writing on this page. The SciSpace Agent prompt screen opens with the template loaded.
- Use the loaded template, or upload a version your group already uses for Cardiovasc Drugs Ther.
- Edit the prompt with your topic and article type, and note any requirement from the Cardiovascular Drugs and Therapy guide for authors.
- Run the prompt. The agent drafts into the correct structure and reference style.
- Use View Outputs to verify required statements and formatting are present.
- Export and submit through the journal's submission system.
Cardiovascular Drugs and Therapy Template Structure at a Glance
| Element | Cardiovasc Drugs Ther requirement |
|---|---|
| Abstract | Structured abstract of 150 to 250 words divided into sections: Purpose (stating the main purposes and research question), Methods, Results, Conclusion. For life science journals, trial registration number and date of registration should be included as the last line of the manuscript abstract. The Editors require that the abstract and results section present relevant numerical values and not be descriptive only |
| Main text | Original Research Articles: max 5000 words (excluding figure legends and references), max 50 references. Short Communications: max 2500 words, max 15 references, up to 2 figures/tables. Letters to the Editor: less than 1000 words, max 4 pages, max 5 references. Editorials: max 2400 words (excluding references and figure legends), max 15 references. Review Articles: no fixed limit but concise presentation expected |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 4 to 6 keywords for indexing purposes |
| References | Numbered citations in square brackets in the text. Reference list numbered consecutively. Use CVDT style in EndNote. All authors listed if 6 or fewer; first 3 followed by et al. if 6 or more. Standard journal abbreviations per ISSN List of Title Word Abbreviations |
| Peer review | Single-anonymized (single-blind) peer review - this is the default Springer policy where author identities are known to peer reviewers but reviewer identities are not revealed to authors. All articles reviewed by two or more referees. |
| Submission | submission.springernature.com/new-submission/10557/3 |
Quick Tips for Using the Cardiovascular Drugs and Therapy Template
Read the Cardiovascular Drugs and Therapy guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Cardiovascular Drugs and Therapy in under a page.
Best Practices
Skim two or three recent Cardiovasc Drugs Ther papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Cardiovascular Drugs and Therapy journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Before You Submit: Final Check
Do one focused pass against the Cardiovascular Drugs and Therapy guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.
